Establishing Radiolabelled PSMA as a Target for Glioma Treatment
Establishing Radiolabelled PSMA as a Target for Glioma Treatment
Not yet recruiting · NCT05263466 · Registry updated 2022-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Establishing Radiolabelled PSMA as a Target for Glioma Treatment | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, malignant glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Not applicable | 2022-06-10 | NCT05263466 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| King's College Hospital NHS Trust | 77 |
| King's College London | 203 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| King's College London | London | United Kingdom | 12 |